Journal of the American Society of Nephrology : JASN · 2014
A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome.
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sadowski Carolin E, Lovric Svjetlana, Ashraf Shazia, Pabst Werner L, Gee Heon Yung, Kohl Stefan, Engelmann Susanne, Vega-Warner Virginia, Fang Humphrey, Halbritter Jan, Somers Michael J, Tan Weizhen, Shril Shirlee, Fessi Inès, Lifton Richard P, Bockenhauer Detlef, El-Desoky Sherif, Kari Jameela A, Zenker Martin, Kemper Markus J, Mueller Dominik, Fathy Hanan M, Soliman Neveen A, SRNS Study Group, Hildebrandt Friedhelm
Аннотация
Steroid-resistant nephrotic syndrome (SRNS) is the second most frequent cause of ESRD in the first two decades of life. Effective treatment is lacking. First insights into disease mechanisms came from identification of single-gene causes of SRNS. However, the frequency of single-gene causation and its age distribution in large cohorts are unknown. We performed exon sequencing of NPHS2 and WT1 for 1783 unrelated, international families with SRNS. We then examined all patients by microfluidic multiplex PCR and next-generation sequencing for all 27 genes known to cause SRNS if mutated. We detected a single-gene cause in 29.5% (526 of 1783) of families with SRNS that manifested before 25 years of age. The fraction of families in whom a single-gene cause was identified inversely correlated with age of onset. Within clinically relevant age groups, the fraction of families with detection of the single-gene cause was as follows: onset in the first 3 months of life (69.4%), between 4 and 12 months old (49.7%), between 1 and 6 years old (25.3%), between 7 and 12 years old (17.8%), and between 13 and 18 years old (10.8%). For PLCE1, specific mutations correlated with age of onset. Notably, 1% of individuals carried mutations in genes that function within the coenzyme Q10 biosynthesis pathway, suggesting that SRNS may be treatable in these individuals. Our study results should facilitate molecular genetic diagnostics of SRNS, etiologic classification for therapeutic studies, generation of genotype-phenotype correlations, and the identification of individuals in whom a targeted treatment for SRNS may be available.
Предметные рубрики MeSH
AdolescentAdultAge of OnsetChildChild, PreschoolCohort StudiesFemaleGenes, Wilms TumorGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHeterozygoteHumansIncidenceInfantIntracellular Signaling Peptides and ProteinsMaleMembrane ProteinsMiddle AgedMutationNephrotic SyndromePedigreePhenotypeReal-Time Polymerase Chain ReactionRetrospective StudiesRisk AssessmentYoung Adult